Clinical Trials Logo
  1. Home
  2. Migraine Headaches
  3. NCT05536635

Effect of Breathing Techniques on Migraine Attacks and Severity

Migraine Headaches Clinical Trial

Official title:
The Effect of Breathing Techniques on Attack Frequency and Severity in Migraine-like Headaches-randomised Control Trial: Study Protocol for a Cluster Randomised Controlled Trial

Clinical Trial Summary

Background: Migraine is a very common neurobiological disorder caused by increased excitability of the Central Nervous System. It is among the causes of the highest morbidity worldwide. Migraine has considerable economic and social impact ; affects the quality of life of patients and disrupts work life, social activities and family life. To decrease the frequency and severity of migraine attacks may be the first goal than treating the attacks. The study was designed as a Parallel Group, Add on, Randomized Controlled Experiment in order to observe the effects of breathing techniques on migraine-like headaches, frequency and severity. Methods: Participants will be divided into 2 parallel arms, intervention and control (treatment as usual). Cluster randomization will be performed to prevent intergroup contamination. Breathing techniques will be taught to the intervention group by the researcher. Both groups will continue to use pharmacotherapy for migraine. Both groups will be evaluated with migraine disability level (MIDAS) at the beginning and end of the study. The primary output of the study is to evaluate the effect of breathing techniques on the frequency and severity of attacks in migraine-like headaches. The secondary output is to evaluate the effect of breathing techniques on the MIDAS level. Discussion: The results of the study will provide information about the effect of breathing techniques on migraine-like headaches. The results of this study will contribute to the literature, since migraine is among the chronic diseases and pharmacotherapy options are limited.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05536635
Study type Interventional
Source Dokuz Eylul University
Contact ogulcan come, MD
Phone 00905398612323
Email ogulcan.come@deu.edu.tr
Status Not yet recruiting
Phase N/A
Start date November 1, 2022
Completion date July 1, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT06342232 - The Efficacy of Neurofeedback Mindfulness in Migraine Management N/A
Completed NCT02351544 - Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches N/A
Completed NCT00665236 - Craniosacral Therapy in Migraine: A Feasibility Study N/A
Completed NCT01706003 - The Utility of Telemedicine in the Management of Migraine
Terminated NCT01944059 - Theramine® in the Prevention of Migraine Headache Phase 4
Terminated NCT01629329 - Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine Phase 4
Completed NCT00792636 - A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period Phase 4
Completed NCT00442221 - The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months Phase 3
Completed NCT02057315 - Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine Phase 1/Phase 2
Completed NCT00109083 - A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine Phase 2
Completed NCT02098499 - Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial Phase 4
Completed NCT00714727 - Set Point Acupuncture for Migraines Using a Digital Assistant Phase 1
Completed NCT00434083 - To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches Phase 3
Completed NCT00960245 - Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions Phase 1
Completed NCT02856802 - An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg) Phase 2
Completed NCT00355056 - PREMIUM Migraine Trial N/A
Completed NCT01118988 - Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents N/A
Completed NCT00433732 - To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches Phase 3
Completed NCT00750594 - Patent Foramen Ovale in Children With Migraine Headaches N/A